SCHEMBL17147372

SCHEMBL17147372

O=C(O)[C@@H]1C[C@@H](O)CN1S(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
MMP3 P08254 3/20 0.47
MMP1 P03956 1/20 0.47
MMP7 P09237 1/20 0.47
ADAM17 P78536 1/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 3/20 0.44
MMP8 P22894 2/20 0.44
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
POLB P06746 1/20 0.43
TRPA1 O75762 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15833066 1.00 MAPT (0.48) MAPTMMP3MMP1MMP7ADAM17
SCHEMBL21716578 0.87 MMP3 (0.47) MAPTMMP3MMP1MMP7ADAM17
SCHEMBL5497274 0.87 MMP2 (0.53) MAPTMMP1ADAM17ALDH1A1L3MBTL1
SCHEMBL5497278 0.87 MMP2 (0.53) MAPTMMP1ADAM17ALDH1A1L3MBTL1
SCHEMBL17822348 0.87 MMP2 (0.53) MAPTMMP1ADAM17ALDH1A1L3MBTL1
SCHEMBL19665777 0.87 MMP2 (0.53) MAPTMMP1ADAM17ALDH1A1L3MBTL1
SCHEMBL5497267 0.87 MMP2 (0.53) MAPTMMP1ADAM17ALDH1A1L3MBTL1
SCHEMBL9215362 0.86 POLB (0.58) MMP1ADAM17ALDH1A1HTTL3MBTL1
SCHEMBL9379038 0.86 POLB (0.58) MMP1ADAM17ALDH1A1HTTL3MBTL1
SCHEMBL21551179 0.86 POLB (0.58) MMP1ADAM17ALDH1A1HTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150284375-A1 HETEROCYCLIC AMIDE DERIVATIVE AND MEDICINE CONTAINING SAME AJINOMOTO CO., INC. (JP) 2015-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284375-A1 HETEROCYCLIC AMIDE DERIVATIVE AND MEDICINE CONTAINING SAME TRPA1, TRPV1, TRPV2 MAPT 1391/4885MMP3 2639/4885MMP1 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.